uniQure N.V. (QURE) Stock

uniQure N.V. (QURE) is a Healthcare stock trading at $46.35 (as of 2026-06-18), with a market capitalization of $1.80B and a trailing P/E of -13.8. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

uniQure N.V. is a gene-therapy company developing treatment candidates for genetic and other diseases. Its pipeline includes Etranacogene dezaparvovec (AMT-061) in a Phase III trial for hemophilia B and AMT-130 in Phase I/II for Huntington’s disease, among other programs for additional neurological and related indications.

Valuation — source: SEC EDGAR (first-party)
Price$46.35
Market Cap$1.80B
P/E Ratio-13.8
EV / EBITDA-16.5
Price / Book20.34
Price / Sales167.87
DCF Value (model)$-48.06
DCF Upside vs Price-203.7%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$16.10M
Net Margin-1236.0%
Return on Equity-139.9%
Debt / Equity0.33
Current Ratio10.40
Revenue Growth (YoY)127.3%
EPS Growth (YoY)3.7%
FCF Growth (YoY)-13.2%
Financial Health — source: SEC EDGAR
Altman Z-Score0.66 (distress)
Piotroski F-Score4/9 (moderate)
Valuation vs Sector & Industry
Stock P/E-13.8
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector-165.8%
vs Industry-179.9%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderAvoro Capital Advisors LLC ($97.44M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOMatthew Craig Kapusta
Employees209
CountryNL
IPO Date2014-02-05

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Biohaven Ltd. (BHVN)
  • Innoviva, Inc. (INVA)
  • Atai Beckley N.V (ATAI)
  • Precigen, Inc. (PGEN)
  • Oruka Therapeutics, Inc. (ORKA)
  • Relay Therapeutics, Inc. (RLAY)
  • Collegium Pharmaceutical, Inc. (COLL)
  • Rapport Therapeutics, Inc. Common Stock (RAPP)
QURE earnings history · QURE institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.